Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.

作者: Antoni Ribas , Begoña Comin-Anduix , James S. Economou , Timothy R. Donahue , Pilar de la Rocha

DOI: 10.1158/1078-0432.CCR-08-0783

关键词:

摘要: Purpose: CTL-associated antigen 4 (CTLA4)-blocking monoclonal antibodies induce long-term regression of metastatic melanoma in some patients, but the exact mechanism is unknown. In this study, biopsies selected accessible tumor lesions from patients treated with tremelimumab were examined to further elucidate its antitumor activity. Experimental Design: Fifteen 7 who had been (CP-675,206) collected. Samples analyzed for markers, immune cell subset presence T regulatory-specific transcription factor FoxP3 and immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO). Results: Clinically responding diffuse intratumoral infiltrates CD8 + cells that markedly increased cases where comparison a baseline biopsy was available. Nonregressing sparse, patchy infiltrates. Patients regressing an frequency or without concomitant increase CD4 cells. Two 3 paired samples showed slight number postdosing biopsies. samples, intensity IDO staining macrophages and/or no clear pattern change postdosing. Conclusions: Administration associated massive CTLs tumors varying effects on expression IDO.

参考文章(46)
Michael Yellin, Alan Korman, Tibor Keler, Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies. Current opinion in investigational drugs. ,vol. 6, pp. 582- 591 ,(2005)
Bevra H. Hahn, Ram Pyare Singh, Antonio La Cava, Fanny M. Ebling, Tolerogenic Treatment of Lupus Mice with Consensus Peptide Induces Foxp3-Expressing, Apoptosis-Resistant, TGFβ-Secreting CD8+ T Cell Suppressors Journal of Immunology. ,vol. 175, pp. 7728- 7737 ,(2005) , 10.4049/JIMMUNOL.175.11.7728
Ajay V. Maker, Peter Attia, Steven A. Rosenberg, Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade Journal of Immunology. ,vol. 175, pp. 7746- 7754 ,(2005) , 10.4049/JIMMUNOL.175.11.7746
Stephen P. Perfetto, Pratip K. Chattopadhyay, Mario Roederer, Seventeen-colour flow cytometry: unravelling the immune system Nature Reviews Immunology. ,vol. 4, pp. 648- 655 ,(2004) , 10.1038/NRI1416
Giao Q. Phan, Peter Attia, Seth M. Steinberg, Donald E. White, Steven A. Rosenberg, Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. Journal of Clinical Oncology. ,vol. 19, pp. 3477- 3482 ,(2001) , 10.1200/JCO.2001.19.15.3477
E. D. Kwon, B. A. Foster, A. A. Hurwitz, C. Madias, J. P. Allison, N. M. Greenberg, M. B. Burg, Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 15074- 15079 ,(1999) , 10.1073/PNAS.96.26.15074
James M. Reuben, Bang-Ning Lee, Changping Li, Jesus Gomez-Navarro, Viviana A. Bozon, Charla A. Parker, Ingrid M. Hernandez, Carolina Gutierrez, Gabriel Lopez-Berestein, Luis H. Camacho, Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma† Cancer. ,vol. 106, pp. 2437- 2444 ,(2006) , 10.1002/CNCR.21854
Ethan M. Shevach, Certified Professionals: Cd4+Cd25+ Suppressor T Cells Journal of Experimental Medicine. ,vol. 193, ,(2001) , 10.1084/JEM.193.11.F41
Wolfgang Herr, Jörg Schneider, Ansgar W. Lohse, Karl-Hermann Meyer zum Büschenfelde, Thomas Wölfel, Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor α in response to HLA-A2.1-binding melanoma and viral peptide antigens Journal of Immunological Methods. ,vol. 191, pp. 131- 142 ,(1996) , 10.1016/0022-1759(96)00007-5
Ulrich Keilholz, Jeffrey Weber, James H. Finke, Dmitry I. Gabrilovich, W. Martin Kast, Mary L. Disis, John M. Kirkwood, Carmen Scheibenbogen, Jeff Schlom, Vernon C. Maino, H. Kim Lyerly, Peter P. Lee, Walter Storkus, Franceso Marincola, Alexandra Worobec, Michael B. Atkins, Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. Journal of Immunotherapy. ,vol. 25, pp. 97- 138 ,(2002) , 10.1097/00002371-200203000-00001